BRAHMS PCT KYPTOR
Device
Brahms GmbH
Total Payments
$250,000
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $250,000 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $250,000 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PROcalcitonin impact on antibiotic reduction, adverSe events and AVoidable healthcarE costs (ProSAVE) | Brahms GmbH | $250,000 | 0 |
Top Doctors Receiving Payments for BRAHMS PCT KYPTOR
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $250,000 | 1 |
Ad
Manufacturing Companies
- Brahms GmbH $250,000
Product Information
- Type Device
- Total Payments $250,000
- Total Doctors 0
- Transactions 1
About BRAHMS PCT KYPTOR
BRAHMS PCT KYPTOR is a device associated with $250,000 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Brahms GmbH.
Payment data is available from 2021 to 2021. In 2021, $250,000 was paid across 1 transactions to 0 doctors.
The most common payment nature for BRAHMS PCT KYPTOR is "Unspecified" ($250,000, 100.0% of total).
BRAHMS PCT KYPTOR is associated with 1 research study, including "PROcalcitonin impact on antibiotic reduction, adverSe events and AVoidable healthcarE costs (ProSAVE)" ($250,000).